APA (7th ed.) Citation

YV, D., AV, K., AK, S., RB, P., N, M., CH, L., . . . CJ, L. (2026). Risk of acute myocardial infarction with ticagrelor, prasugrel, and clopidogrel prescription after coronary stent restenosis: A retrospective real-world comparative risk analysis with TriNetX. Heart & lung : the journal of critical care, 78, 102752. https://doi.org/10.1016/j.hrtlng.2026.102752

Chicago Style (17th ed.) Citation

YV, Dhruva, Kumar AV, Shah AK, Ponnada RB, Mootz N, Lu CH, Peddada VP, and Lin CJ. "Risk of Acute Myocardial Infarction with Ticagrelor, Prasugrel, and Clopidogrel Prescription After Coronary Stent Restenosis: A Retrospective Real-world Comparative Risk Analysis with TriNetX." Heart & Lung : The Journal of Critical Care 78 (2026): 102752. https://doi.org/10.1016/j.hrtlng.2026.102752.

MLA (9th ed.) Citation

YV, Dhruva, et al. "Risk of Acute Myocardial Infarction with Ticagrelor, Prasugrel, and Clopidogrel Prescription After Coronary Stent Restenosis: A Retrospective Real-world Comparative Risk Analysis with TriNetX." Heart & Lung : The Journal of Critical Care, vol. 78, 2026, p. 102752, https://doi.org/10.1016/j.hrtlng.2026.102752.